Skip to content

Clinical trials

Completed Hepatitis C trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Status: Completed Country / region: China Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20091
20114
20131
20142
20151
20163
20175
20183
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Bristol-Myers Squibb3
Kawin Technology Share-holding Co., Ltd.3
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.2
Gilead Sciences2
The First Hospital of Jilin University2
Centers for Disease Control and Prevention1
Hong Ren1
Hospital Authority, Hong Kong1
Nanjing Sanhome Pharmaceutical, Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C24
Hepatitis C, Chronic6
Fibrosis4
Coinfection3
Hepatitis B3
Acquired Immunodeficiency Syndrome2
Hepatitis2
Drug Misuse1
Liver Cirrhosis1
Purpura1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.